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Abstract
Pseudomonas aeruginosa is ubiquitously present in the environment and acts as an opportunistic pathogen on humans,
animals and plants. We report here the effects of the prebiotic polysaccharide inulin and its hydrolysed form FOS on this
bacterium. FOS was found to inhibit bacterial growth of strain PAO1, while inulin did not affect growth rate or yield in a
significant manner. Inulin stimulated biofilm formation, whereas a dramatic reduction of the biofilm formation was
observed in the presence of FOS. Similar opposing effects were observed for bacterial motility, where FOS inhibited the
swarming and twitching behaviour whereas inulin caused its stimulation. In co-cultures with eukaryotic cells (macrophages)
FOS and, to a lesser extent, inulin reduced the secretion of the inflammatory cytokines IL-6, IL-10 and TNF-a. Western blot
experiments indicated that the effects mediated by FOS in macrophages are associated with a decreased activation of the
NF-kB pathway. Since FOS and inulin stimulate pathway activation in the absence of bacteria, the FOS mediated effect is
likely to be of indirect nature, such as via a reduction of bacterial virulence. Further, this modulatory effect is observed also
with the highly virulent ptxS mutated strain. Co-culture experiments of P. aeruginosa with IEC18 eukaryotic cells showed
that FOS reduces the concentration of the major virulence factor, exotoxin A, suggesting that this is a possible mechanism
for the reduction of pathogenicity. The potential of these compounds as components of antibacterial and anti-inflammatory
cocktails is discussed.
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Introduction
Strains of P. aeruginosa are ubiquitously present in the
environment [1], which is due to their capacity to colonize
different ecological niches [2,3] and metabolic versatility [4]. P.
aeruginosa is an opportunistic pathogen able to infect different
animals and plants [5,6], being a frequent cause of hospital-
acquired infections including ventilator associated pneumonia [7]
and catheter infections in immuno-compromised patients. P.
aeruginosa lung infections are the main cause of morbidity and
mortality in cystic fibrosis (CF) patients [8]. The bacterium is
highly resistant to antibiotic treatment and difficult to eradicate
once established in the host [9]. One of the important antibiotic
resistance mechanisms is the formation of biofilms [10], hence a
great deal of attention has been given to the study of the molecular
mechanisms involved in its generation, maturation and dispersal
[11,12]. It has been shown that flagella and type IV pili-mediated
motility are required for efficient biofilm formation [13–15].
Bacteria use different secretion systems to inject virulence
factors into the cytoplasm of eukaryotic cells, leading to bacterial
replication within macrophages and, consequently, evasion from
the immune system [16]. In Gram-negative bacteria several
secretion systems have been characterized, referred to as type I to
type VI systems [17,18]. The type II (T2SS) and type III secretion
system (T3SS) secrete the majority of known toxins [19]. They
differ in their molecular mechanisms and operate on several
substrates. The secretion system type I is an ABC transporter
composed of an ABC protein, a membrane fusion protein and an
outer membrane protein. This system transports various molecules
of diverse nature such as ions, drugs, and proteins [20]. Similarly,
type II and V secretion systems generally transport proteins to the
surface of the host cell and are involved in the extracellular release
of various toxins and hydrolytic enzymes such as exotoxin A, Las
A, Las B, protease and elastase [21,22]. In contrast, the type III
secretion system (T3SS) injects proteins, small molecular weight
compounds and hydrolytic enzymes into the cytosol of eukaryotic
cells [23], which corresponds to a potent virulence mechanism
shared by many pathogenic Gram-negative bacteria. This protein
injection in turn triggers a cytoskeletal reorganization of the host
cell as shown by the inhibition of P. aeruginosa internalization upon
incubation with cytochalasin D [24], which destroys microfila-
ments, thereby preventing further uptake of bacteria [16,23,25].
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A significant number of natural compounds have been found to
inhibit bacterial growth, although their mechanism of action
remains unclear in most cases [26,27]. Here we report a study on
the activity of the fructo-oligosaccharides (FOS) and inulin on P.
aeruginosa proliferation. Inulin is a linear polymer formed by 20 to
over 60 b-2,1-linked fructose monomers with a terminal glucose
residue, whereas FOS are short-chain oligosaccharides with the
same structure but a maximal chain length of 2 to 20 monomeric
units which are generated by hydrolysis of inulin [28]. Inulin is
found in different nutrients such as wheat, onion, garlic and banana
[29]. Inulin and FOS are considered prebiotics, based on the
observation that they promote the growth of certain beneficial gut
bacteria such as bifidobacteria [30,31], but they have been also
found to inhibit the growth of pathogenic bacteria such as Salmonella
typhimurium [32], S. enteritidis [33] Listeria monocytogenes or the fungus
Candida albicans [34]. In addition inulin and FOS have been found to
have a beneficial impact on human health, including the stimulation
of calcium, iron and zinc absorption [35] and the modulation of
local and systemic immune responses [36].
Here we show that the addition of FOS to P. aeruginosa PAO1
cultures decreases growth and biofilm formation. This effect
appears to be specific for FOS since it was not observed following
inulin treatment. In addition, FOS reduces the cytokine response
of rat primary monocytes to P. aeruginosa infection, an effect
considered indirect since this oligosaccharide was found to activate
the NF-kB pathway. Attenuated responses are observed also with
the virulent ptxS mutant strain. Exotoxin A production is lowered
by FOS treatment, suggesting that FOS may interfere with
exotoxin synthesis and/or secretion. Taken together, our data
suggest that FOS may be a useful component of drug cocktails for
the treatment of P. aeruginosa infections.
Results
Differential effect of FOS and inulin on the growth of P.
aeruginosa PAO1
As stated in the introduction, a number of natural compounds
can either promote or slow down the growth of microorganisms.
To assess the effect of inulin and FOS on P. aeruginosa, growth
curves were recorded in minimal medium M9 supplemented with
citrate. Under these conditions only minor changes in the bacterial
growth rate and yield were observed in the presence of 5–20 mg/
ml inulin. Namely, 5 and 15 mg/ml of inulin resulted in a slight to
moderate stimulation of growth, whereas at the concentration of
20 mg/ml a slight reduction was noted (Fig. 1A).
Similarly, in the presence of 5–15 mg/ml of FOS a minor
stimulation of bacterial growth was noted (Fig. 1B); however, at
the concentration of 20 mg/ml a marked inhibition was observed
(Fig. 1B). Since inulin and FOS differ only in the carbohydrate
chain length, this parameter appears to be central for antibacterial
activity. In comparison, a growth curve was recorded in the
presence of 20 mg/ml of control goat milk oligosaccharides (OS),
showing promotion of bacterial growth at the same concentration
at which FOS inhibits growth. In fact, both FOS and inulin (at 15–
20 mg/ml) are able to support bacterial growth when M9 minimal
medium is used (data not shown).
Reduction of biofilm formation in the presence of FOS
To assess the influence of FOS and inulin on biofilm formation,
P. aeruginosa PAO1 was cultured in 24-well plates in the absence or
presence of different concentrations of both compounds for
6 hours (Fig. 2A), followed by a quantification of biofilm
formation. Fig. 2 B and Fig. S1 show the relative amount of
biofilm formation as a function of the inulin/FOS concentration
(logarithmic scale). It became apparent that both compounds have
opposite effects; whereas inulin stimulated biofilm formation, FOS
had a concentration dependent inhibitory effect. Fitting of data
(Fig. 2B) resulted in an EC50 value of 2.1 mg/ml for FOS
(inhibition) and 5.8 mg/ml for inulin (stimulation). Biofilm
formation was almost completely inhibited at a FOS concentration
of 4–8 mg/ml, which is in sharp contrast with inulin that
produced a ,10-fold enhancement at concentrations up to
approximately 10 mg/ml.
Subsequently, biofilms formed in the presence or absence of
both compounds (at 20 mg/ml) were observed under the
microscope (Fig. 2C). To this end bacteria were grown in M9
minimal medium supplemented with 0.2% (w/v) glucose, 0.4%
(wt/v) casamino acids and with inulin or FOS. In control
conditions clear biofilm formation was observed after 4 and
6 hours of culture, as expected (Fig. 2C). Similar results were
obtained with 20 mg/ml of inulin, but the biofilm was more
prominent after 6 h as compared to the control sample. In
contrast, while biofilm formation in the presence of FOS was
comparable to that in control conditions after 4 hours, it was
virtually absent at 6 h (Fig. 2C).
FOS and inulin have opposite effects on bacterial motility
P. aeruginosa has been shown to exhibit three different types of
motility, namely swimming, swarming and twitching [37,38].
Twitching motility across solid surfaces [39] has been found to be
required for biofilm development [13,40], as well as for a
persistent colonization of lungs, and it is associated with virulence
in corneal infection models [39,41]. We have studied the effect of
inulin and FOS at 5 mg/ml on P. aeruginosa bacterial motility on
agar plates and in bacterial suspension (Fig. 3). Neither FOS nor
inulin affected swimming behaviour (Fig. 3A). Interestingly, FOS
inhibited both swarming and twitching motility, whereas inulin
treatment resulted in the opposite effect, i.e. stimulation (Fig. 3B
and C).
Inulin and FOS reduce cytokine secretion in P. aeruginosa
infected macrophages
Tissue injury or infection results in the recruitment and
activation of host immune cells. Macrophages are the first immune
cells likely to encounter P. aeruginosa. The activation of macro-
phages is based largely on the recognition of pathogens by
molecular pattern receptors, including Toll-like receptors (TLRs),
such as TLR4 [16,42]. Macrophages can internalize and kill
bacterial pathogens; however, during P. aeruginosa infections their
role in pathogen sensing is of primary importance [43]. This in
turn causes significant changes in gene expression and the
secretion of proinflammatory cytokines IL-6 and TNF-a that
recruit inflammatory cells in response to bacterial virulence
factors, while IL-10 tends to mitigate this response [44–47]. These
are among the main signalling mediators released by monocyte/
macrophages.
Initial experiments were carried out to establish the experimen-
tal conditions for the assessment of the effect of FOS and inulin on
cytokine secretion (Fig. S2). Macrophages were incubated with P.
aeruginosa PAO1 and interleukin 6 secretion was measured at
different time intervals (Fig. S2). Maximal secretion was observed
after 4 hours of incubation. Therefore, these experimental
conditions were used to quantify the effect of FOS/inulin on the
secretion of IL-6, IL-10 and TNF-a.
In the absence of bacteria (Fig. 4, column –PAO1), inulin and
FOS had no significant effect on cytokine secretion, although a
slight increase was noted. PAO-1 infection caused the expected
significant increase in cytokine secretion. This response was
Effects of FOS on Pseudomonas aeruginosa
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markedly attenuated for the three cytokines in the presence of
FOS, while inulin caused exclusively a reduction in IL-6 levels
(Fig. 4). These data therefore show that the presence of inulin and
particularly FOS reduced the inflammatory response of macro-
phages to bacterial infection. Since FOS/inulin did not reduce the
cytokine release in the absence of bacteria, our results suggest that
the inhibitory effect of FOS is probably due to a direct interaction
with P. aeruginosa.
Activation of the NF-kB signal transduction pathway is
downregulated by FOS
The mitogen-activated protein kinase (MAPK) and the NF-kB
signalling pathways are implicated in the production of TNF-a
and IL-6 in macrophages [48]. In addition, it has been reported
that P. aeruginosa infection is associated to stimulation of TLR4
receptors, leading to an activation of the NF-kB pathway [49]. To
assess the impact of inulin and FOS on the inflammatory response,
the role of the NF-kB and MAPK signalling pathways in the FOS-
mediated modulation of macrophages was assessed. One of the
ways to activate NF-kB by extracellular stimuli involves the rapid
degradation of IkB-a as a consequence of IkB-a phosphorylation
at Ser32 by IkB kinase, which corresponds to IKK in the so-called
canonical pathway. We studied the effect of inulin and FOS on the
activation (phosphorylation) of IkB-a and MAPK, ERK, JNK and
p38 by Western blot analysis in macrophages infected with P.
aeruginosa. As shown in Fig. 5A, neither FOS nor inulin affected the
phosphospecific signal of the three MAPK, suggesting that they
are not involved in the observed changes. In contrast, FOS but not
inulin reduced IkB-a phosphorylation, pointing to a modulation of
the NFk-B canonical pathway.
Moreover, the activation of the NF-kB transcription factor is
associated with the nuclear translocation of the p65 component of
the complex. To confirm the effect of inulin or FOS on nuclear
NF-kB/p65 translocation, p65 was quantified by ELISA in cell
nuclei following 1 h activation. In contrast to inulin, FOS (5 mg/
ml) effectively reduced NF-kB/p65 translocation (Fig. 5B).
Therefore, the effect of FOS is associated with a minor activation
of the NF-kB signalling pathway.
Figure 1. Effect of inulin and FOS on the growth of P. aeruginosa PAO1. Growth curves in minimal medium M9 supplemented with 50 mM
citrate in the absence and presence of inulin (A) and FOS (B) are shown. As a control, growth in the minimal medium M9 supplemented with 20 mg/
ml of goat milk oligosaccharides (OS) is shown. Growth curves were recorded at 37uC for 24 hours. Representative data from one of three
independent experiments with similar results are shown.
doi:10.1371/journal.pone.0085772.g001
Effects of FOS on Pseudomonas aeruginosa
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The effect of FOS is observed in P. aeruginosa mutant
strains with different degrees of virulence
Since the FOS-mediated inhibition of bacterial growth and
biofilm formation may reduce virulence, we hypothesized that the
response of eukaryotic cells to infection may be modulated by the
presence of this oligosaccharide. Subsequent experiments were
aimed at assessing the effect of FOS and inulin in two strains of P.
aeruginosa showing different levels of virulence compared as
compared to wild type strain. We used mutants deficient in PtxS
and PtxR, two transcriptional regulators that control the
expression of the toxA gene, encoding the exotoxin A virulence
factor [50].
Figure 2. Formation of P. aeruginosa biofilm. A) Biofilm formation in the absence and presence of different concentrations of FOS and inulin in
24-well plates. Biofilm formation was monitored in M9 minimal medium supplemented with 0.2% (w/v) glucose and casamino acids and quantified
after 6 h. B) The relative amounts of biofilm formation in the experiments shown in Fig. 2A are plotted against the logarithm of inulin/FOS
concentration. Data were fitted with the sigmoidal model of the ORIGIN software package to determine EC50 values. Data are the average of three
independent assays. C) Microscopic inspection of biofilm formation in the absence and in the presence of 20 mg/ml inulin or FOS at 2, 4 and 6 hours.
doi:10.1371/journal.pone.0085772.g002
Effects of FOS on Pseudomonas aeruginosa
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Both, PtxR and PtxS play a role in regulating the activity from
the PtoxA promoter [51]. Mutation of ptxS increases toxA expression
by a factor of ,4, whereas deletion of ptxR causes a ,2-fold
reduction [51].
The increase in toxicity of the ptxS mutant (Fig. 6A) is reflected
in the colour of bacterial cultures due to the increased production
of the bright blue-green siderophore pyocyanin, an important
virulence factor of fluorescent Pseudomonads [52–54]. In contrast
the colour of the ptxR mutant is similar to that of the wild type
strain. Further, anti-exotoxin A western blot showed that ptxS
mutant produces significantly more exotoxin A than the ptxR
mutant (Fig. 6B). Subsequently, the cytotoxic activity of P.
aeruginosa on macrophages was analysed 4 hours after infection,
using the Cytotox 96H non-radioactive cytotoxicity assay kit. As
expected, cytotoxicity was highest for the ptxS mutant (Fig. 6C)
where approximately 25% of cells died, followed by the wild type
strain (10% of cell death) and the ptxR mutant for which no toxicity
was detected (Figure 6C). The lactase dehydrogenase (LDH) is a
marker for cytotoxicity. We have determined the LDH levels of
0.1–0.2 mU/ml in the absence of bacteria but in the presence of
FOS or inulin (data not shown). Both compounds did not induce
any significant changes in the LDH levels, indicating that they are
not cytotoxic to macrophages under the conditions used (data not
shown).
As expected, the cytokine secretory response followed the same
pattern, being higher with the ptxS mutant, followed by the wild
type and lower for the ptxR mutant (Fig. 7) (Data from Fig. 4 are
included for comparison) [51]. For all three bacterial strains
analysed, FOS caused a very pronounced reduction (Fig. 7), while
inulin caused a more moderate reduction. Interestingly, the FOS/
inulin mediated reduction was more pronounced in the ptxS
mutant than in WT strain, suggesting that virulent strains may be
more sensitive to the effect of fructose oligosaccharides.
P. aeruginosa employs a number of systems to secrete proteins
which play different roles during infection. To analyse the role of
FOS or inulin on P. aeruginosa virulence, exotoxin A was quantified
in supernatants of bacterial co-cultures with eukaryotic cells as well
as within eukaryotic cells. To achieve a good separation of
eukaryotic cells from bacteria, we used the rat small intestinal cell
line IEC18 that grows on surfaces and exhibits inflammatory
responses [55,56]. Bacteria are removed by a washing step with
fresh PBS solution, leaving an intact IEC18 cell monolayer
containing infecting Pseudomonas. Anti-exotoxin A western blot
analysis showed that the addition of FOS and inulin to eukaryotic
cells did not alter exotoxin A levels present in the culture medium
(data not shown). In contrast, FOS was found to reduce
intracellular exotoxin A levels in IEC18 cells co-cultured with P.
aeruginosa, whereas no significant change was observed in the
presence of inulin (Fig. 8A and B). These data suggest that the type
II-dependent exotoxin A secretion from P. aeruginosa to the cell
cytosol is inhibited by FOS, presumably limiting its virulence.
Because we cannot rule out the presence of extracellular, cell
adherent bacteria in the sample, it may be possible that FOS also
downregulates exotoxin A in extracellular Pseudomonas.
Discussion
Prebiotics are defined as compounds that have beneficial effects
on humans by altering the intestinal microbiota in a manner that is
beneficial to health. The mechanism of their action is not clear,
but it is thought to involve preferential utilization of oligosaccha-
rides by host-friendly bacterial species such as bifidobacteria or
lactobacilli, indicating that prebiotic substances might have the
capacity to protect against infections and reduce the presence of
clinically relevant pathogens in the faecal flora [57,58]. Another
proposed mechanism involves enhanced bacteriocin secretion by
lactobacilli [59], which in turn facilitates the incorporation of
bacteria into a niche and inhibits the invasion of competing strains
or pathogens, leading ultimately to a modulation of the microbiota
and of the host immune system.
Therefore, the inhibition of pathogens by prebiotics is thought
to be largely due to indirect effects [60]. However, antimicrobial
properties have been described for a number of oligosaccharides
[61]. To our knowledge this is the first report showing that FOS,
one of the most studied and used prebiotics, has specific effects on
P. aeruginosa PAO1. We were able to show that FOS (1) inhibits
P. aeruginosa growth, biofilm formation and motility; (2) limits
the P. aeruginosa evoked NF-kB dependent cytokine secretion in
Figure 3. Effects of FOS and inulin on the motility of P.
aeruginosa. Motility assays were carried out as described in materials
and methods. Inulin or FOS at 5 mg/ml was present in the agar plates
and in the bacterial suspensions. A) Swimming assays. B) Swarming
assays and C) Twitching assays. Average values of the distances of
bacterial migration are shown. Data are the average of three
independent assays. Values are means 6 s.e.m., n = 6; *P,0.05 vs
without effectors (ANOVA followed by least significance tests).
doi:10.1371/journal.pone.0085772.g003
Effects of FOS on Pseudomonas aeruginosa
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Figure 4. Effect of inulin and FOS on inflammatory response of macrophages against P. aeruginosa (WT). Macrophages were incubated
with WT P. aeruginosa cells (ratio 1/5) for 4 hours in either the absence or the presence of 5 mg/ml FOS and inulin prior to the determination of IL-6
(A), IL-10 (B) and TNF-a secretion (C). Values are means 6 s.e.m., n = 6–8; *P,0.05 vs macrophage without bacteria and &P,0.05 vs WT in the absence
of inulin or FOS (ANOVA followed by least significance tests).
doi:10.1371/journal.pone.0085772.g004
Effects of FOS on Pseudomonas aeruginosa
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macrophages; and (3) decreases exotoxin A levels in P. aeruginosa
infected IEC18 cells.
These effects have also been observed for inulin, but in general
the magnitude of the changes induced by FOS was superior to that
of inulin. This indicates that the length of the oligosaccharide
chains is an essential determinant for the magnitude of the
biological activities observed. This is exemplified by growth
inhibition: both FOS and inulin can be used as carbon and
energy source by P. aeruginosa and it is therefore not surprising to
see a growth stimulation in the presence of up to 10 mg/ml of
both compounds (Fig. 1 and data not shown). However, at a
concentration of 20 mg/ml inulin had a very modest effect on
growth which contrasts with FOS that caused a very significant
growth inhibition. These results are consistent with a biphasic
response of P. aeruginosa to FOS/inulin: growth is stimulated at low
concentrations of inulin and then inhibited to a certain extent; the
same response is observed with FOS, but growth inhibition is
clearly more pronounced. The control goat milk oligosaccharides
did not produce any inhibition at similar concentrations,
underlining the specificity of action of FOS.
The variety of cellular processes modulated by FOS was a
surprising finding and it is tempting to speculate that glycoside
receptors may be involved in the recognition of FOS and that
these receptors signal via different cascades modulating different
cellular processes. Such a mechanism would be comparable to that
for the sensing of other antimicrobial glycosides [62]. Otherwise,
biofilm formation is a major mechanism that confers bacterial
resistance and biofilm induced antibiotics tolerance is of major
clinical importance [63]. Currently significant research efforts are
being made to identify compounds that interfere with biofilm
formation, maturation and dispersion and to explore their effect in
infection models [64]. Here we show that FOS and inulin have
opposite effects on biofilm formation. While inulin caused a
Figure 5. FOS but not inulin reduces the amount of phosphor-
ylated IkB-a. A) Macrophages were infected with P. aeruginosa in the
absence or presence of either 5 mg/ml FOS or inulin. After 4 h growth
Western blots were performed using cell extracts and the correspond-
ing antibodies against ERK (Extracellular Regulated Kinase), p-ERK (the
phosphorylated form of Extracellular Regulated Kinase), p-P38 (activat-
ed and phosphorylated form of P38 mitogen-activated protein kinases),
p-JNK (Jun N-terminal kinases) and after 1 h for p-IkB-a (activated form
in the NF-kB canonical pathway). As control, actin was quantified in all
samples using an anti-a-actin antibody. Duplicate samples in the
absence of added effectors and triplicate samples in the presence of
FOS and inulin are shown. B) NF-kB activation was determined by
measuring the nuclear translocation of the p65 component, expressed
as the OD450 nm.
*P,0.05 vs macrophage without bacteria and &P,0.05
vs WT in the absence of inulin or FOS (ANOVA followed by least
significance tests).
doi:10.1371/journal.pone.0085772.g005
Figure 6. Effect of wild type and mutant P. aeruginosa PAO1 on
macrophages. A) Cultures of P. aeruginosa PAO1 and its mutants
deficient in ptxS and ptxR were grown in M9 Minimum medium
supplemented with 50 mM citrate for 24 hours. The blue-green colour
is indicative of an increased pyocyanin secretion. B) Western blot
determination of exotoxin A concentration secreted by P. aeruginosa
WT and its isogenic mutants ptxS and ptxR. C) The macrophage
mortality induced by WT P. aeruginosa and its ptxS and ptxR mutants
was measured by the total release of cytoplasmic lactate dehydroge-
nase (LDH). *P,0.05 vs macrophage without bacteria and &P,0.05 vs
macrophage with WT (ANOVA followed by least significance tests).
doi:10.1371/journal.pone.0085772.g006
Effects of FOS on Pseudomonas aeruginosa
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Figure 7. Effect of inulin and FOS on inflammatory response of macrophages against WT P. aeruginosa and its isogenic mutants ptxS
and ptxR. Macrophages were incubated with WT and mutant P. aeruginosa cells (ratio 1/5) for 4 hours in either the absence or the presence of 5 mg/
ml FOS and inulin prior to the determination of IL-6 (A), IL-10 (B) and TNF-a secretion (C). Values are means 6 s.e.m., n = 6–8; *P,0.05 vs WT in the
absence of inulin or FOS; &P,0.05 vs ptxS mutant without effectors (ANOVA followed by least significance tests).
doi:10.1371/journal.pone.0085772.g007
Effects of FOS on Pseudomonas aeruginosa
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stimulation, a dramatic reduction was observed in the presence of
FOS (Fig. 2 and Fig. S1). Interestingly, FOS did not appear to
affect the early stages of biofilm formation since no significant
changes were observed after 4 hours growth (Fig. 2C). In turn, a
dramatic reduction was seen after 6 hours (Fig. 2C), suggesting
that FOS interferes with later stages of biofilm formation or
triggers its dispersal. Further experiments to elucidate this point
are underway.
We hypothesized that these effects may alter P. aeruginosa
virulence. In order to test this hypothesis, we infected rat primary
monocyte cultures with PAO1 and measured cytokine release in
the presence and absence of oligosaccharides. Monocytes display
an enhanced release of cytokines in response to infection, which
was shown to be chiefly dependent on NF-kB activation and p65
nuclear translocation. These are early changes associated with
modest cytotoxicity due to the short incubation time. Remarkably,
treatment with FOS attenuated significantly all the steps of this
response, i.e. secretion of IL-6, IL-10 and TNF-a, IkB-a
phosphorylation and p65 nuclear translocation (Figs. 4 and 5).
Inulin in contrast had a significantly more moderate effect. In the
absence of bacteria neither FOS nor inulin caused an effect on
cytokine secretion and their long-term effect on macrophages (and
intestinal epithelial cells) is an activation of the NF-kB pathway
[65] and thus contrary to the oligosaccharide reduction of pathway
activity. Thus it follows that the inhibited NF-kB response in this
case is likely to be of indirect nature, i.e. borne out of a reduced
stimulation by P. aeruginosa infection, confirming our hypothesis.
This may also explain why inulin failed to inhibit IkB-a
phosphorylation, since it is also capable of activating this signalling
pathway; however, it is unclear why inulin decreases IL-6 and IL-
10 secretion. Our data suggest that MAPK is not involved in this
process.
We then investigated potential links between FOS and other
determinants of P. aeruginosa virulence, such as the PtxS and PtxR
regulators that modulate exotoxin A expression (Fig. 6B). Muta-
tion of the corresponding genes showed the expected alterations in
cytokine release and cytotoxicity in infected monocytes, respec-
tively, confirming previous observations [51]. These changes
correlated with toxA expression, since the highest cytokine
secretion/toxA transcription was observed in the ptxS mutant,
followed by the WT strain and the ptxR mutant [51]. It is therefore
likely that exotoxin A plays a role in stimulating cytokine secretion
in the host cell. The main finding of this series of experiments is
that FOS exerts its modulatory effects also on the more virulent
ptxS mutant. Of note, the effect of inulin was somewhat increased
compared to that on the wild type, although always lower than
that of FOS. Our results therefore suggest that FOS effectively
reduces the virulence of 3 different strains of P. aeruginosa.
Modulation of exotoxin A expression or transport can probably
be associated with this effect.
P. aeruginosa is an opportunistic pathogen and can infect
immunocompromised individuals at different sites such as the
respiratory tract, intestine, skin, urinary tract, and wounds. The
severity of the opportunistic infection depends to a great extent on
the virulence factors expressed by the bacterium, which in turn
influence cytotoxicity and antibiotic resistance. As a result P.
aeruginosa infections are notoriously difficult to treat. Several classes
of antibiotics including cephalosporins, penicillins, carbapenems,
quinolones and aminoglycosides are currently been used to
combat P. aeruginosa clinically, but specific sensitivity testing is
mandatory [66]. Our data suggest that FOS may be a useful
component of a drug cocktail to combat P. aeruginosa infection.
Alternatively, it appears also plausible to use FOS in a
prophylactic context to prevent gastrointestinal infections. Oral
FOS supplements are currently been used to prevent gastrointes-
tinal infections [67], which implies that the oral route may be also
valid to administer FOS to fight Pseudomonas infection. However,
any clinical application will require an extensive study of the
potential effects of FOS on the human body which are issues that
are to be addressed in the future.
Materials and Methods
Animals
Wistar rats (200–250 g) obtained from the Animal Service
Laboratory of the University of Granada (Spain) were used,
housed in macrolon cages, and maintained in air-conditioned
animal quarters with a 12-h light-dark cycle. Rats were given free
access to tap water and food. This study was carried out in
accordance with the Directive for the Protection of Vertebrate
Animals used for Experimental and other Scientific Purposes of
the European Union (86/609/EEC) and the animal protocol used
has been approved by the ethics committee of the Granada
University.
Bacterial strains used in this study
P. aeruginosa PAO1 and its mutants deficient in ptxS and ptxR
obtained through insertion of streptomycin and tetracycline
cassettes, respectively [51], were grown in LB medium or M9
minimal medium (Na2HPO4: 6 g/l; KH2PO4: 3 g/l; NaCl: 0.5 g/
l; NH4Cl: 1 g/l, 1 mM MgSO4, 0.3 mM CaCl2 and 0.2 ml/l of
1% ferric ammonium citrate) [68]. When required, antibiotics
were added to the culture medium to reach a final concentration
of 50 mg/ml ampicillin, 50 mg/ml streptomycin and 30 mg/ml
tetracycline.
Figure 8. FOS reduces exotoxin A expression. A) Western blot
determination of the cellular concentration of exotoxin A in IEC18 cells
following co-culture with P. aeruginosa in the presence and absence of
FOS and inulin. B) Densitometric analysis of above data. Exotoxin A
densities were corrected with those obtained for a-actin. Values are
means 6 s.e.m., n = 3; &P,0.05 vs macrophage/WT without inulin or
FOS (ANOVA followed by least significance tests).
doi:10.1371/journal.pone.0085772.g008
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Chemicals
Inulin and FOS were provided by BENEO-Orafti (Tienen,
Belgium). FOS and inulin were kindly provided by BENEO
OraftiH (Tienen, Belgium). OraftiH GR (inulin) is a food ingredient
consisting mainly of chicory root inulin, a mixture of oligo- and
polysaccharides which are composed of fructose units linked
together by b(2-1) linkages. Almost every molecule is terminated
by a glucose unit. The total number of fructose or glucose units
( = Degree of Polymerization or DP) of chicory inulin ranges
mainly between 2 and 60. OraftiH P95 oligofructose (FOS) is
produced by the partial enzymatic hydrolysis of chicory-derived
inulin, consisting mainly of molecules with DP between 2 and 8.
Solutions were made at 200 g/l in M9 minimal medium and, in
the case of eukaryotic cell cultures, in Dulbecco’s Modified Eagle
Medium (DMEM) containing fetal bovine serum (10%), 2 mM L-
glutamine, and 2.5 mg/mL amphotericin B, all provided by
Sigma. Solutions were filtered using 0.22 mm cut-off filters and
aliquots were stored at 220uC. The goat milk oligosaccharides
(OS) were obtained according to the method described in [69]. A
product containing .80% of the original oligosaccharide content,
only 5% (w/w) of lactose and virtually salt free, was obtained and
used to carry out all the experiments.
Effects of inulin and FOS on P. aeruginosa growth
Individual colonies of P. aeruginosa PAO1 were picked from the
surface of freshly grown LB plates and grown overnight in M9
minimum medium (supplemented with 5 mM of citrate) at 37uC.
The overnight culture was diluted with fresh M9 minimum
medium to an OD660 nm of 0.05 and 96 well flat-bottomed
polystyrene microtiter plates were filled with 180 ml of this cellular
suspension. Then, 20 ml of either inulin or FOS were added to
reach final concentrations of 5, 15 and 20 mg/ml. Plates were
incubated at 37uC under continuous agitation in a Bioscreen C
MBR analyser FP-1100-C (OY Growth Curves Ab Ltd., Raisio,
Finland). The turbidity was measured using a wideband filter at
420–660 nm every 60 minutes over a 24 h period. The measure-
ments at 580 nm were used to generate growth curves. Some
cultures were carried out with the same medium without citrate.
Semiquantitative determination of biofilm formation
Semiquantitative determination of biofilm formation was
performed as described [70]. Experiments were conducted in 24
well flat-bottomed polystyrene microtiter plates in M9 minimal
medium supplemented with 0.2% (w/v) of glucose and 0.4% (w/v)
casamino acids in the absence and in the presence of different
concentrations (up to 20 mg/ml) of inulin or FOS. Biofilm
formation was quantified after 6 h by staining with crystal violet
following the method described in [71]. The structure of biofilms
was observed under contrast-phase microscopy using a Zeiss
Axioscope fluorescence microscope coupled to a Nikon DSS-Mc
CCD camera and a 100-fold magnifier. Data reported are means
from two independent experiments each conducted in quadruplet
repeats.
Motility assays
Assays were carried out to determine the effect of inulin and
FOS (each at a concentration of 5 mg/ml) on swimming,
twitching and swarming. In all assays these compounds were
added at identical concentrations to the bacterial suspension in the
plates. For swimming assays bacteria were placed with the help of
a sterile tooth-pick at the centre of plates containing a 5 mm layer
of LB medium with 0.3% (w/v) Bacto agar, 0.2% casamino acids
(w/v) and 30 mM glucose. Plates were incubated at 37uC for 24 h
and the radial diffusion of bacteria, due to swimming, was
measured. To monitor twitching motility bacteria were placed
with a toothpick into a 2 mm thick layer containing 1.5% (w/v)
Bacto agar, 0.2% (w/v) casamino acids and 30 mM glucose. After
incubation for 24 h at 37uC, the expansion of bacteria on the plate
was observed. For swarming assays 5 ml of an overnight culture of
bacteria were placed into the centre of swarm plates, which are
made of 0.5% (w/v) Bacto agar supplement with 0.2% (w/v)
casamino acids and 30 mM glucose. Plates were incubated at
37uC for 24 h, followed by an inspection of the bacterial surface
movement [72]. All the motility assays were performed in
triplicates.
Macrophage cell isolation by magnetic activated cell
sorting
Female Wistar rats were sacrificed by cervical dislocation and
the spleen was extracted aseptically. Cell suspensions were
obtained by disrupting the tissues between dissecting forceps in
medium. After centrifugation (15006rpm/5 min), cells were
cleared of erythrocytes by resuspension in hypotonic lysis buffer
(15 mM NH4Cl, 10 mM KHCO3, 0.1 mM Na2EDTA, pH 7.3)
for 30 min on ice. Mononuclear cells were washed and
resuspended in MACs buffer (PBS containing 0.5% (w/v) BSA,
2 mM EDTA, pH 7.2). To obtain a monocellular suspension, cells
were passed through 70 mm nylon mesh prior to magnetic
labelling and subsequently isolated by negative selection. To
remove lymphocytes, CD161.1-biotin (1:200), CD45RA-PE
(1:200) and CD3 (1:150) (Biosciences), were added and incubated
at 4uC for 30 min. Cells were washed and sedimented by
centrifugation at 15006rpm for 5 min. After resuspension in
MACs buffer, 25 ml of each antibiotin Microbeads and anti-PE-
microbeads (Miltenyi Biotec), were added and the resulting
suspension incubated at 4uC during 30 min. Cells were washed,
centrifuged and dissolved in DMEM medium (Dulbecco’s
Modified Eagle Medium). CD161.1+, CD45RA+ and CD3+ cells
were discarded using an LD column (Miltenyi Biotec). Macro-
phages in the flow-through were centrifuged at 15006rpm for
5 min and resuspended in Dulbecco’s Modified Eagle Medium
(DMEM Sigma H) supplemented with 10% FBS (sigma), 2.5 mg/L
amphotericin B and 2 mM L-glutamine.
Measurement of inulin- and FOS-induced changes in
cytokine secretion from macrophages following infection
by P. aeruginosa PAO1
For the determination of cytokine levels the macrophage
suspensions (106 cells/ml DMEM medium) were co-cultured with
P. aeruginosa and incubated with 5 mg/ml FOS or inulin for
4 hours. Following centrifugation at 4uC and 10.0006rpm for
5 min, the resulting supernatants were frozen at 280uC. Aliquots
were thawed and cytokine levels determined using ELISA-based
kits (BD Biosciences, Erembodegem, Belgium) following the
protocol provided by the manufacturer. In addition, macrophage
cells were used for the quantification of phosphorylated IkB-a and
MAP kinases by Western blot determination as described below.
Western blot
For the detection of ERK, p-ERK, p-P38, p-JNK and
phosphorylated IkB-P, cells were homogenized in lysis buffer
(PBS containing 0.1% (w/v) SDS, 0.1% (w/v) sodium deoxycho-
late, 1% (v/v) Triton X-100) with protease inhibitor cocktail
(Sigma) 1:100 (v/v). Subsequently, homogenates were sonicated
and centrifuged 70006g for 5 min at 4uC. Protein concentrations
were determined using the Bicinchoninic acid assay [73]. Samples
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were boiled in 56 Laemmli buffer (220 mM Tris, 312 mM SDS,
50% (v/v) glycerol, 1% (v/v) 2-mercaptoethanol, 22.5 mM
EDTA, pH 6.8, containing traces of bromphenol blue) for
5 min, separated by SDS-PAGE, electroblotted to PVDF mem-
branes (Millipore, Madrid, Spain), and exposed to the primary
antibodies against ERK, p-ERK (both from Sigma), p-P38, p-JNK
and phosphorylated IkB-P, respectively (all three from Cell
signalling, Danvers, MA). Prior to exposure to the secondary
IgG Peroxidase antibody (anti-mouse IgG for ERK and p-ERK,
anti-rabit IgG for p-P38, p-JNK and p-IkB, (Sigma) the bands
were visualized by enhanced chemiluminescence (PerkinElmer,
Waltham, MA) and quantified with the NIH software (Scion
Image).
Determination of the NF-kB p65 subunit in macrophages
nuclear extracts
Macrophages were co-cultured with P. aeruginosa with a 1:5 ratio
and incubated with FOS (5 mg/ml) or inulin (5 mg/ml). After 1 h,
nuclear extracts were obtained using a nuclear extract kit (Active
Motif, Belgium) and NF-kB activation was determined by
quantifying the p65 component using a TransAM kit following
the protocols recommended by the manufacturers (Active Motif,
Belgium).
Cytotoxicity Assays
Measurement of P. aeruginosa induced cytotoxicity in macrophages:
Macrophages were incubated with P. aeruginosa with a ratio of
1:5 for 4 hours and the percentage of cytotoxicity was determinate
using cytotox 96 non-radioactive cytotoxicity assay kit following
the protocols recommended by the manufacturers (Promega)
which evaluates cytotoxicity by assessing the total release of
cytoplasmic lactate dehydrogenase (LDH), by the calorimetric
detection, into culture medium as a consequence of damaged cell
membranes [74].
Determination of exotoxin A concentration in rat IEC18
cells infected by P. aeruginosa PAO1
IEC18 cells were cultured in 6 well plates. At confluence IEC18
cells were infected with P. aeruginosa at a ratio of 5 bacterial cells
per eukaryotic cell in the absence and in the presence of 5 mg/ml
FOS or inulin. Plates containing cells were washed 3 times with
PBS and incubated with gentamicin at 100 mg/ml for 1 h to
eliminate bacteria. Subsequently, plates were washed 3 times with
PBS prior to cell collection using RIPA buffer [25 mM Tris–HCl,
pH 7.2, 150 mM NaCl, 0.1% sodium deoxycholate and 0.1%
sodium dodecyl sulfate (SDS)] containing a protease inhibitor
cocktail (Sigma). Proteins were extracted for Western blot analysis,
as described above. Western blot were carried out as outlined
above using the Exotoxin A antibody (Sigma) at a 1:2.000 dilution.
Following overnight incubation with the primary antibody the
membrane was incubated with the secondary IgG Peroxidase anti-
rabbit antibody (Sigma) at a 1:3.000 dilution for two hours. The
bands were detected by enhanced chemiluminescence (PerkinEl-
mer, Waltham, MA) and quantified with NIH software (Scion
Image).
Statistical analysis
All results are expressed as means with the corresponding
standard deviations. Differences among means were analysed for
statistical significance by a one-way ANOVA analysis and a
posteriori least significance test. All analyses were carried out using
the SigmaStat 2.03 program (Jandel Corporation, San Rafael,
CA). Concentration-response curves were fitted to a logarithmic
curve when possible with Origin 7.0 (OriginLab Corporation,
Northampton, MA). Differences were considered significant at
P,0.05.
Supporting Information
Figure S1 The OD at 560 nm of crystal violet (CV)
stained and resuspended bacteria from biofilm are
given. Shown are means and standard deviations with n = 3–6;
*P,0.05 vs WT in the absence of inulin or FOS (ANOVA
followed by least significance tests). The densitometric analysis of
experiments is shown in Fig. 2A.
(TIF)
Figure S2 Measurement of interleukin-6 secretion of
macrophages in the presence of WT P. aeruginosa PAO1
and its ptxS and ptxR mutants. The macrophage/bacteria
ratio was of 1:5. Experimental conditions involving incubation for
4 hours were subsequently used to assess the effect of FOS and
inulin on interleukin secretion as reported in Fig. 4 and 7. Values
are means 6 s.e.m., n = 3; *P,0.05 vs macrophage without
bacteria and &P,0.05 vs macrophage with WT (ANOVA
followed by least significance tests).
(TIF)
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